Verastem VSTM
NASDAQ VSTM
$8.14 +0.16 (+1.94%)
As of: Sep 4, 2026 · 3:15 PM EDT

Verastem (VSTM) Share-based Compensation (2011 - 2026)

Verastem (VSTM) posted quarterly Share-based Compensation of $2.5 million for Q1 2026, up 40.66% year-over-year from $1.8 million in Q1 2025, and up 24.2% quarter-over-quarter from $2.0 million in Q4 2025.

Analysis

Verastem (VSTM) Share-based Compensation (2011 - 2026) Analysis & Trends

Verastem's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.5 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 40.66% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $10.1 million (up 683.53% YoY), while the FY2025 annual figure was $9.4 million, up 851.82% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $2.5 million, up from $2.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $3.4 million in Q2 2025, with the low at -$4.3 million in Q4 2024.
  • The 5-year median for Share-based Compensation is $1.6 million (2022), against an average of $1.5 million.
  • The sharpest annual moves came in 2024 and 2025: Share-based Compensation tumbled 371.28% in 2024, then jumped 146.71% in 2025.
  • Verastem's Share-based Compensation stood at $1.3 million in 2022, then gained by 24.16% to $1.6 million in 2023, then sank by 371.28% to -$4.3 million in 2024, then surged by 146.71% to $2.0 million in 2025, then advanced by 24.2% to $2.5 million in 2026.
  • Business Quant data shows VSTM's Share-based Compensation at $2.5 million in Q1 2026, $2.0 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 277.20 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 41.25 Mn
10 Verastem 815.95 Mn 679.59 Mn 36.32 Mn 3.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.70 Mn
Mar 31, 2026 3.33 Mn
Dec 31, 2025 2.03 Mn
Sep 30, 2025 2.96 Mn
Jun 30, 2025 2.95 Mn
Mar 31, 2025 2.46 Mn
Dec 31, 2024 2.02 Mn
Sep 30, 2024 2.38 Mn
Jun 30, 2024 2.22 Mn
Mar 31, 2024 2.12 Mn
Dec 31, 2023 1.60 Mn
Sep 30, 2023 2.12 Mn
Jun 30, 2023 2.01 Mn
Mar 31, 2023 23.72 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 13.65 Mn
Jun 30, 2022 16.54 Mn
Mar 31, 2022 15.94 Mn
Dec 31, 2021 1.57 Mn
Sep 30, 2021 12.95 Mn